Clinical Trials for Metastatic Cancer

Find clinical trials for metastatic cancer. Discover research opportunities and treatment options in your area.

115 Active Trials Found

Showing 115 trials on this page

Page 6 of 6

A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer

NCT ID: NCT06184035

This clinical trial is investigating a new treatment called [177Lu]Lu-SN201 for adults with advanced solid tumors, which are cancers that have spread and cannot be surgically removed. The main goal...

Recruiting

Phase: PHASE1 Type: interventional Locations: Adelaide, South Australia, Australia, Melbourne, Victoria, Australia

Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer

NCT ID: NCT04989725

This clinical trial is looking at a treatment called stereotactic ablative radiotherapy (SABR) for patients with metastatic head and neck cancer who have a limited number of new cancer spots, known...

Recruiting

Phase: PHASE2 Type: interventional Locations: Montréal, Quebec, Canada

Metastases Directed Therapy for Oligometastatic Breast Cancer

NCT ID: NCT06144346

This clinical trial is looking at a new treatment approach for women with a specific type of breast cancer known as oligometastatic breast cancer, where the cancer has spread but is limited to a sm...

Recruiting

Phase: NA Type: interventional Locations: Cairo, , Egypt

Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool.

NCT ID: NCT05245136

The Augsburg Longitudinal Plasma Study is a clinical trial designed to explore how a new testing method called liquid biopsy can help in diagnosing and understanding metastatic cancer, which is can...

Recruiting

Type: observational Locations: Augsburg, Bavaria, Germany

Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer

NCT ID: NCT06121700

This clinical trial is exploring a new treatment approach for patients with limited metastatic gastric or gastroesophageal junction cancer, which is a type of stomach cancer that has spread a littl...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

NCT ID: NCT06010875

This clinical trial is investigating a new treatment approach using a special type of immune cell therapy called CAR-T cells that target a protein called CD70. The goal is to see how safe and effec...

Recruiting

Phase: PHASE1 Type: interventional Locations: Nanchang, Jiangxi, China

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

NCT ID: NCT05094804

This clinical trial is studying a new treatment called OR2805, which is a type of medication known as a monoclonal antibody. It aims to see how safe and effective OR2805 is when given alone or in c...

Recruiting

Phase: PHASE1 Type: interventional Locations: Scottsdale, Arizona, United States, San Antonio, Texas, United States +1 more

Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN

NCT ID: NCT05260671

This clinical trial is studying a new treatment option for adults with recurrent or metastatic squamous cell carcinoma of the head and neck, which is a type of cancer that can come back after treat...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, , China, Changchun, Jilin, China

Efficacy of Point Of Service Testing in MBC

NCT ID: NCT03983577

This clinical trial is looking at a new way to provide cancer genetics counseling for patients with HER2 negative metastatic breast cancer (MBC). The goal is to see if this innovative approach can ...

Recruiting

Phase: NA Type: interventional Locations: Kansas City, Kansas, United States

Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers

NCT ID: NCT05296564

This clinical trial is studying a new treatment called HBI 0201-ESO TCR-Gene Engineered Lymphocytes, which is designed to help patients with certain types of metastatic cancers that express a prote...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jerusalem, , Israel

A Phase II Stydy of Bevacizumab Plus Erlotinib in Patients for Krebs Cycle Altered Cancer

NCT ID: NCT05904457

This clinical trial is exploring the effects of two drugs, bevacizumab and erlotinib, on patients with advanced solid tumors that have specific genetic changes related to the Krebs cycle, which is ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seoul, , Korea, Republic Of, Seoul, , Korea, Republic Of +9 more

Thiopurine Enhanced Mutations for PD-1/Ligand-1 Efficacy

NCT ID: NCT05276284

The TEMPLE study is a clinical trial exploring a new treatment for adult patients with advanced or metastatic solid tumors, which means cancer that has spread from its original site to other parts ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Copenhagen, , Denmark

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

NCT ID: NCT05422911

This clinical trial is studying the effectiveness of three different medications—abiraterone, enzalutamide, and apalutamide—in treating Veterans with castrate-sensitive prostate cancer that has spr...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Bronx, New York, United States

A Study to Examine the Clinical Value of Comprehensive Genomic Profiling Performed by Belgian NGS Laboratories: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Centre

NCT ID: NCT05058937

The BALLETT study is a clinical trial focusing on how comprehensive genomic profiling (CGP) can improve treatment options for patients with advanced solid tumors and metastatic cancer. This study a...

Recruiting

Phase: NA Type: interventional Locations: Gent, , Belgium, Leuven, , Belgium +10 more

Prediction of Drug Response Using an Ex Vivo Organ Culture (EVOC) on Fresh Human Tumour Samples From Metastatic Patients

NCT ID: NCT04599608

This clinical trial is investigating a new method called the Curesponse Ex Vivo Organ Culture (EVOC) to help predict how well certain cancer treatments will work for patients with advanced or metas...

Not yet recruiting

Type: observational

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions